Skip to main content
. 2018 Feb 1;10:20. doi: 10.3389/fnagi.2018.00020

FIGURE 8.

FIGURE 8

Atrial natriuretic peptide pre-treatment reverses the neurotoxin-induced changes in β-catenin phosphorylation and degradation and in the expression of DA neuron specific markers and survival factors in SHSY5Ydiff cells. WB (A) and densitometric (B–D) analyses of the expression levels of TH, Nurr1, DJ-1 and phospho-AktT308, and total and phosphorylated β-catenin (pβ-cateninT41/S65), in SHSY5Ydiff cells subjected to 7h and 24h 6-OHDA challenging in absence and in presence of 30 min or 24 h pre-treatment with ANP. In the panel of WB (A), the duration of each treatment is reported above the corresponding lane. Values from densitometric analysis were normalized to β-actin, or vs the total levels of β-catenin or AKT for the phosphorylated forms. Significance vs untreated control (Ctr); #Significance vs 6OH-Dopa: p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; the mean ± SD; n = 3.